Latest Series A Funding Rounds

Companies raising their first major institutional growth round, from the product they sell to the investors backing their next stage.

This page showsStage: Series A
Rounds
878
All time
Disclosed funding
$34.1B
792 disclosed amounts
Median round
$20M
Of disclosed amounts
878 rounds
Funding rounds
CompanyAmountRoundSectorCountryInvestorsAnnounced
Science4BeautyBiotech · PolandCompany profile

A Polish skincare company using a recombinant conotoxin active ingredient in anti-wrinkle creams and other products sold directly to consumers and through aesthetic-medicine channels.

A Polish skincare company using a recombinant conotoxin active ingredient in anti-wrinkle creams and other products sold directly to consumers and through aesthetic-medicine channels.

PLN 7MSeries ABiotechPolandInvestors
AUDEREnterprise software · JapanCompany profile

Smartphone-based shipment inspection software that connects food suppliers' dispatch records with receiving warehouses.

Smartphone-based shipment inspection software that connects food suppliers' dispatch records with receiving warehouses.

¥450MSeries A first closeSeries AEnterprise softwareJapanInvestors
SirdabLogistics · Saudi ArabiaCompany profile

Sirdab connects businesses with warehouse and transport capacity across Saudi Arabia and the GCC, while helping providers and shippers coordinate inventory, orders and service quality.

Sirdab connects businesses with warehouse and transport capacity across Saudi Arabia and the GCC, while helping providers and shippers coordinate inventory, orders and service quality.

$10MSeries ALogisticsSaudi ArabiaInvestors
CradlewiseConsumer · —Company profile

Cradlewise makes smart cribs that monitor infant sleep and provide soothing intended to help babies settle and stay asleep.

Cradlewise makes smart cribs that monitor infant sleep and provide soothing intended to help babies settle and stay asleep.

$12MSeries AConsumer—Investors
WaferHardware · United StatesCompany profile

Wafer runs AI inference infrastructure that adapts a model-serving stack to each customer's workload. It benchmarks and tunes models, engines, kernels and available hardware together, then keeps optimizing live serving for latency, reliability and cost as traffic changes.

Wafer runs AI inference infrastructure that adapts a model-serving stack to each customer's workload. It benchmarks and tunes models, engines, kernels and available hardware together, then keeps optimizing live serving for latency, reliability and cost as traffic changes.

$40MSeries AHardwareUnited StatesInvestors
Business Nextgen Finance Private LimitedFintech · IndiaCompany profile

Business Nextgen Finance is a non-bank lender providing secured credit to underserved small businesses in India.

Business Nextgen Finance is a non-bank lender providing secured credit to underserved small businesses in India.

₹2.2BSeries AFintechIndiaInvestors
SiccaNova TherapeuticsBiotech · JapanCompany profile

A biotechnology company developing an oral drug candidate for dry mouth and related gland-function disorders.

A biotechnology company developing an oral drug candidate for dry mouth and related gland-function disorders.

¥1.3BSeries ABiotechJapanInvestors
Kimi no Tonari, Inc.AI · JapanCompany profile

The developer of Uratchi, an AI fortune-telling app offering personalized relationship guidance and chat readings.

The developer of Uratchi, an AI fortune-telling app offering personalized relationship guidance and chat readings.

UndisclosedSeries AAIJapanInvestors
Typewriter TherapeuticsBiotech · United StatesCompany profile

Typewriter Therapeutics is developing an all-RNA gene-writing platform that inserts therapeutic genes at a defined genomic site without viral vectors or double-strand DNA breaks. Its programs target in vivo engineered CAR-T cells and gene insertion for severe genetic diseases, including liver disorders.

Typewriter Therapeutics is developing an all-RNA gene-writing platform that inserts therapeutic genes at a defined genomic site without viral vectors or double-strand DNA breaks. Its programs target in vivo engineered CAR-T cells and gene insertion for severe genetic diseases, including liver disorders.

$56MSeries ABiotechUnited StatesInvestors
PeopleX, Inc.AI · JapanCompany profile

An enterprise AI software provider offering recruiting interviews, role-play training and employee conversations.

An enterprise AI software provider offering recruiting interviews, role-play training and employee conversations.

¥5.5BSeries AAIJapanInvestors

Active investors in this selection

All investors →

Ranked by rounds participated in · All time

  1. 1
    Y Combinator (YC)

    Clueso, Santé, Flai

    52rounds
    0led
  2. 2
    Andreessen Horowitz (a16z)

    Eka Robotics, TypeSafe AI, Sharp Performance

    29rounds
    9led
  3. 3
    General Catalyst

    Baba, Melius, Disha (formerly Curelink)

    24rounds
    1led
  4. 4
    Lightspeed

    Warp Sciences, Zenzap, Avarra

    21rounds
    4led
  5. 5
    Alumni Ventures

    Chariot Claims, RegCell, Inc., Lightfield

    21rounds
    0led

Latest digests

Archive →

Explore published rounds while the next edition is being prepared.

Browse rounds by topic